Clinical Trial Update: EVR and EPO for Liver Transplant Tolerance [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial sponsored by NIAID is evaluating everolimus (EVR) and erythropoietin (EPO) for inducing tolerance in liver transplant recipients; recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Erythropoietin (erythropoietin)
• Everolimus (everolimus)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Liver Transplant | Phase 1 | Status: RECRUITING